Serum-Free Medium for Mesenchymal Stem Cells

CelliMax® MSC Medium by Application

MSC function — proliferation, differentiation potential, secretome and immunophenotype — is shaped by the expansion medium. Serum adds an undefined, lot-dependent variable to every application. Below is how a chemically defined, animal-free MSC medium changes the picture in the four most common settings.

Cell therapy & ATMP manufacturing

EMA and FDA expect full traceability of every raw material in an ATMP process. Serum-based MSC expansion carries an undefined biological input through every production run. CelliMax® MSC is chemically defined and free of animal-derived components: no TSE/BSE risk, simpler raw-material qualification and no requalification for each new serum lot. MSC immunophenotype (CD73, CD90, CD105) is maintained over multiple passages, and the medium works in 2D culture and on microcarriers for bioreactor scale-up. It is produced under ISO 13485 and EXCiPACT at GMP grade, in powder and liquid formats at production scale — batch sizes on request. CoA, TSE/BSE declaration and composition disclosure are available for IND and IMPD dossiers.

Tissue engineering & 3D models

Construct quality depends on the cells that go into the scaffold. Serum pre-conditions MSCs with undefined growth factors before seeding. Defined expansion preserves osteogenic, chondrogenic and adipogenic potential and gives a consistent surface-marker profile — for more reproducible scaffold attachment, chondrogenic pellet or hydrogel culture, bone mineralisation assays and organoid co-culture. The liquid format suits R&D-scale work; the powder format reduces cold-chain logistics for larger scaffold pipelines.

Basic research & differentiation studies

FBS contains active TGF-β, IGF-1, PDGF and lipid mediators — the very pathways many MSC studies investigate. A defined medium removes this background for Wnt and TGF-β/SMAD signalling studies, multilineage differentiation, migration and invasion assays, MSC–niche interaction and single-cell RNA-seq, where serum drives artificial transcriptional subpopulations. Methods sections can name a documented formulation instead of "10% FBS". Bone-marrow, adipose and umbilical-cord MSCs expand without coating or substrate modification.

Drug discovery & CRO screening

Serum-lot changes shift MSC proliferation, differentiation bias and cytokine secretion — CROs see this as unexplained drift between screening batches. With a defined medium, MSCs used in fibrosis co-culture, osteoarthritis/cartilage, NF-κB inflammation and metabolic disease models keep the same functional state from batch to batch, which stabilises assay windows and Z-factors. The powder format allows in-house reconstitution on a fixed schedule, with full documentation per batch.

Working on MSC-derived extracellular vesicles or immunomodulation? See serum-free MSC medium for exosome & EV production and MSC medium for immunomodulation and secretome research.